Evidence map›Paper›PMID 35806939›Full record

ArticleJournal of clinical medicine2022

Collapsing Glomerulonephritis in a Kidney Transplant Recipient after mRNA SARS-CoV-2 Vaccination.

Francisco Gómez Preciado, Rosa Alejandra De Carvalho Ovalles, Sergi Codina, Laura Donadeu, Alexandre Favà, Laura Martinez Valenzuela, Diego Sandoval, Bárbara Fernández-Cidón, Oriol Bestard, Pedro Alia-Ramos and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Francisco Gómez PreciadoDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Rosa Alejandra De Carvalho OvallesPathology Department, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Sergi CodinaDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.ORCID 0000-0002-2313-6109
Laura DonadeuLaboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-5089-5047
Alexandre FavàDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Laura Martinez ValenzuelaDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Diego SandovalDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Bárbara Fernández-CidónClinical Laboratory, IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0001-5547-480X
Oriol BestardKidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain.
Pedro Alia-RamosClinical Laboratory, IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Montserrat GomàPathology Department, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Edoardo MelilliDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Josep M CruzadoDepartment of Nephrology, Hospital Universitari de Bellvitge (HUB), 08907 Barcelona, Spain.
Bellvitge University Hospital · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), studies are describing cases of glomerulonephritis arising after vaccination. We present the first case of a kidney transplant patient who, after mRNA vaccination against SARS-CoV-2, developed nephrotic proteinuria and renal dysfunction, with a biopsy diagnostic of collapsing glomerulonephritis. No other triggers for this glomerulonephritis were identified. Antibodies against the spike protein were negative, but the patient developed a specific T-cell response. The close time between vaccination and the proteinuria suggests a possible determinant role of vaccination. We should be aware of nephropathies appearing after COVID-19 vaccination in kidney transplant recipients also.

Indexed as

collapsingCOVID-19glomerulonephritismRNASARS-CoV-2vaccine

Identifiers

PMID35806939
PMCPMC9267596
OpenAlexW4283520172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.